Opendata, web and dolomites

iHealth-T2D SIGNED

Family-based intervention to improve healthy lifestyle and prevent Type 2 Diabetes amongst South Asians with central obesity and prediabetes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iHealth-T2D project word cloud

Explore the words cloud of the iHealth-T2D project. It provides you a very rough idea of what is the project "iHealth-T2D" about.

24    pakistan    screening    hba1c    index    south    physical    intervention    power    usual    treatment    quarter    80    uk    prediabetes    family    weight    members    100cm    men    sessions    utility    diet    primary    followed    session    will    coupled    gt    care    thereby    population    trial    scalability    complete    group    diagnosis    secondary    burden       base    glucose    healthy    limited    intensive    effectiveness    annually    locations    734    efficient    billion    promotion    evaluation    60    vs    community    onset    circumference    india    worker    economic    worldwide    strategy       socio    world    gender    endpoint    central    asian    equitable    tolerance    cluster    obesity    endpoints    t2d    physician    lanka    compare    diabetic    active    clinical    diabetes    lifestyle    predicted    ge    sri    reverse    health    asians    randomised    120    sites    impaired    30    prevention    modification    amongst    women    22    epidemic    waist    preventing    risk    scalable    600    poor   

Project "iHealth-T2D" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.ihealth-t2d.eu
 Total cost 3˙614˙083 €
 EC max contribution 3˙614˙083 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-HCO-2014
 Funding Scheme RIA
 Starting year 2015
 Duration (year-month-day) from 2015-01-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 1˙386˙972.00
2    LONDON NORTH WEST HEALTHCARE NATIONAL HEALTH SERVICE TRUST UK (HARROW MIDDLESEX) participant 749˙537.00
3    DEVKI DEVI FOUNDATION SOCIETY IN (NEW DELHI) participant 247˙050.00
4    UNIVERSITY OF SURREY UK (GUILDFORD) participant 244˙233.00
5    SERVICES INSTITUTE OF MEDICAL SCIENCES PK (Lahore) participant 176˙900.00
6    OULUN YLIOPISTO FI (OULU) participant 166˙990.00
7    UNIVERSITY OF COLOMBO LK (COLOMBO WESTERN PROVINCE) participant 155˙550.00
8    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 146˙250.00
9    UNIVERSITY OF KELANIYA LK (KELANIYA) participant 121˙237.00
10    PUNJAB INSTITUTE OF CARDIOLOGY (PIC) LAHORE PK (LAHORE PUNJAB) participant 113˙612.00
11    INSTITUTE FOR HEALTH POLICY LK (COLOMBO) participant 105˙750.00
12    EALING HOSPITAL NHS TRUST UK (SOUTHALL) participant 0.00

Map

 Project objective

South Asians, who represent one-quarter of the world’s population, are at high risk of type-2 diabetes (T2D). Intensive lifestyle modification (healthy diet and physical activity) is effective at preventing T2D amongst South Asians with impaired glucose tolerance, but this approach is limited by high-cost, poor scalability and low impact on T2D burden. We will complete a cluster-randomised clinical trial at 120 locations across India, Pakistan, Sri Lanka and the UK. We will compare family-based intensive lifestyle modification (22 health promotion sessions from a community health worker, active group, N=60 sites) vs usual care (1 session, control group, N=60 sites) for prevention of T2D, amongst 3,600 non-diabetic South Asian men and women with central obesity (waist≥100cm) and/or prediabetes (HbA1c≥6.0%). Participants will be followed annually for 3 years. The primary endpoint will be new-onset T2D (physician diagnosis on treatment or HbA1c≥6.0%, predicted N~734 over 3 years). Secondary endpoints will include waist and weight in the index case and family members. Our study has 80% power to identify a reduction in T2D risk with family-based intervention vs usual care of: 30% in South Asians with central obesity; 24% in South Asians with prediabetes; and 24% overall. Health economic evaluation will determine cost-effectiveness of family based lifestyle modification for prevention of T2D amongst South Asians with central obesity and / or prediabetes. The impact of gender and socio-economic factors on clinical utility and cost-effectiveness will be investigated. Our results will determine whether screening by waist circumference and/or HbA1c, coupled with intervention by family-based lifestyle modification, is an efficient, effective and equitable strategy for prevention of T2D in South Asians. Our findings will thereby provide a robust evidence base for scalable community-wide approaches to reverse the epidemic of T2D amongst the >1.5 billion South Asians worldwide.

 Deliverables

List of deliverables.
Web Dissemination Websites, patent fillings, videos etc. 2020-03-11 10:38:00
Targeted Dissemination Other 2020-03-11 11:50:37
Final Reports on Outcomes Data Documents, reports 2020-03-11 11:50:39
Health Economic Analysis Documents, reports 2020-03-11 10:38:01
Report on Intervention Documents, reports 2019-09-02 09:23:07
Report on Recruitment Documents, reports 2019-09-02 09:23:07
Project Website Websites, patent fillings, videos etc. 2019-09-02 09:23:07

Take a look to the deliverables list in detail:  detailed list of iHealth-T2D deliverables.

 Publications

year authors and title journal last update
List of publications.
2020 Mirthe Muilwijk1*, Marie Loh2,3*, Sara Mahmood4, Saranya Palaniswamy3,5, Samreen Siddiqui6, Wnurinham Silva3, Gary S. Frost7, Heather M. Gage8, Marjo-Riitta Jarvelin3,5,9,10, Ravindra P. Rannan-Eliya11, Sajjad Ahmed12, Sujeet Jha6, Anuradhani Kasturiratne13, Prasad Katulanda14, Khadija I. Khawaja4, Jaspal S. Kooner15,16, Ananda R. Wickremasinghe13, Irene G.M. van Valkengoed1**, John C. Chambers2,3
The iHealth-T2D study: Statistical analysis plan for a cluster randomised controlled trial with intensive family-based lifestyle modification programme to reduce type 2 diabetes risk amongst South Asians
published pages: , ISSN: , DOI:
Trials 2020-03-05

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IHEALTH-T2D" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IHEALTH-T2D" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More  

FAIR (2020)

FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA

Read More